News Release

Cardiovascular risk reclassification with the 2026 Dyslipidemia Guideline

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: Adoption of the 2026 American College of Cardiology/American Heart Association/Multisociety Dyslipidemia Guideline and Predicting Risk of Cardiovascular Disease EVENTs (PREVENT)-ASCVD (atherosclerotic cardiovascular disease) reclassified approximately one-quarter of adults, with two-thirds of those reassigned to lower-risk categories and one-third reassigned to higher-risk categories. Males, non-Hispanic Black individuals, and currently smoking individuals were most frequently reassigned downward, whereas females and individuals with diabetes were more often reassigned upward.

Corresponding Author: To contact the corresponding author, Allison W. Peng, MD, email apeng4@jh.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2026.11152)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.11152?guestAccessKey=b8c84aa0-8620-40cb-8bbe-4a84ce4a3343&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072026


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.